arrow_back Back to App

Accelerating Valley Fever Vaccine Development, Manufacturing, and National Registry

This Act authorizes funding and establishes a coordinated federal strategy to accelerate the development, licensing, and manufacturing of a human vaccine for Valley Fever (coccidioidomycosis) by 2034. The legislation aims to enhance public health security by pursuing effective protection against this fungal disease. It also creates a national registry to collect data and better track the disease's prevalence.
Key points
Establishes a National Strategy and appoints a Vaccine Coordinator to achieve the goal of having a licensed vaccine by 2034.
Authorizes $50 million in funding for grant and contract programs supporting research, clinical development, and initial manufacturing of the vaccine.
Creates the National Valley Fever Registry under the CDC to collect non-personal data on cases and improve disease monitoring.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_9942
Sponsor: Rep. Duarte, John S. [R-CA-13]
Process start date: 2024-10-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Valley Fever Awareness and Vaccine Development and Manufacturing Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_9942.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-10-08.

What are the main provisions?

Key points include:

  • Establishes a National Strategy and appoints a Vaccine Coordinator to achieve the goal of having a licensed vaccine by 2034.
  • Authorizes $50 million in funding for grant and contract programs supporting research, clinical development, and initial manufacturing of the vaccine.
  • Creates the National Valley Fever Registry under the CDC to collect non-personal data on cases and improve disease monitoring.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Duarte, John S. [R-CA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health